New protein discovery may have implications for treating deadly E. coli infection

Main Category: MRSA / Drug Resistance
Article Date: 14 Nov 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (4 votes)

Healthcare Prof:4 and a half stars

4.5 (2 votes)


A discovery by Queen's researchers of a previously unknown protein may open the door to more effective treatment of a deadly strain of the E. coli bacteria.

A team led by biochemistry researcher Zongchao Jia and graduate student Michael Suits has identified a protein that allows the bacterial strain known as E. coli 0157:H7 to obtain the iron it needs for survival in the body.

Iron is a catalyst for bacterial growth, so when a human body detects bacterial invasion, it naturally produces proteins that bind tightly to and restrict iron to limit bacterial growth. In response, bacteria have evolved other methods to acquire iron including detecting and using human heme within proteins such as hemoglobin that transports oxygen from our lungs.

The newly discovered protein breaks down heme, releasing the iron atom stored there for use by the deadly bacteria.

"This discovery opens the door for studying the function of heme iron in this strain of E. coli, and may lead to an understanding of how to therapeutically isolate the protein to keep the bacteria from thriving," says Dr. Jia.

E. coli 0157:H7 is responsible for the fatal illnesses in the Walkerton tragedy, the illness known as "Hamburger Disease" and the recent evacuation of over a thousand residents from the Kasechewan First Nation reserve. It is most commonly transmitted through undercooked meat, unpasturized milk and infected water sources.

Researchers believe that isolating one of the proteins E. coli 0157:H7 needs for survival will not be enough, however, since the bacteria will migrate to surrounding proteins as iron sources.

Ongoing research is required to examine the functions of several different proteins to find an effective treatment for E. coli 0157:H7, similar to the cocktail used to treat other severe bacterial infections. The results of the Queen's study, funded by the Canadian Institutes for Health Research (CIHR) are available at PNAS online (www.pnas.org) today.

Lorinda Peterson
lorinda.peterson@queensu.ca
Queen's University
queensu.ca

Article adapted by Medical News Today from original press release.
Visit our mrsa / drug resistance section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Daniel Chavez. "New protein discovery may have implications for treating deadly E. coli infection." Medical News Today. MediLexicon, Intl., 14 Nov. 2005. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/33367.php>

APA
Daniel Chavez. (2005, November 14). "New protein discovery may have implications for treating deadly E. coli infection." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/33367.php.

Please note: If no author information is provided, the source is cited instead.


MRSA / Drug Resistance

Most Popular Articles



Follow Our MRSA News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our MRSA / Drug Resistance Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »